首页 › 基金 › ORBIMED ADVISORS LLC › QURE
ORBIMED ADVISORS LLC 对 QURE 的持仓历史
UNIQURE NV · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 QURE(UNIQURE NV)1,807,486 股,市值约 US$83.3M,约占其申报组合的 1.67%,在其申报持仓中市值排名第 14 位。 ORBIMED ADVISORS LLC 最近 12 个申报季度中有 6 个季度披露了 QURE 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 QURE 的持仓演变
ORBIMED ADVISORS LLC 于 Q3 2023 首次披露 QURE 持仓:2,064,455 股(约 US$13.9M)。 该持仓在 Q2 2026 达到峰值 1,807,486 股,市值约 US$83.3M。 在 6 次申报中,ORBIMED ADVISORS LLC 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,807,486 股、市值约 US$83.3M,环比减持 -328,663 股。。 持仓曾出现大幅变动:Q4 2023 减持约 35% (随后一个季度股价下跌 23%)、Q4 2025 增持约 61% (随后一个季度股价下跌 32%)、Q1 2026 增持约 190% (随后一个季度股价上涨 182%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.06M | $13.85M | 新进 |
| Q4 2023 | 1.35M | $9.13M | 减持 |
| Q3 2025 | 458.50K | $26.76M | 新进 |
| Q4 2025 | 737.40K | $17.65M | 增持 |
| Q1 2026 | 2.14M | $34.93M | 增持 |
| Q2 2026 | 1.81M | $83.25M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 QURE 与 13F 数据
QURE(UNIQURE NV)属于医疗保健行业。我们追踪的基金中还有 64 只申报持有 QURE,申报仓位最大的包括:Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), Boxer Capital Management, LLC (US$69.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 QURE 的基金
- Avoro Capital Advisors LLC 6.73M 股 · $309.88M · Q2 2026
- RTW INVESTMENTS, LP 3.94M 股 · $181.55M · Q2 2026
- Boxer Capital Management, LLC 1.50M 股 · $69.24M · Q2 2026
- MAK CAPITAL ONE LLC 1.23M 股 · $56.75M · Q2 2026
- MPM BioImpact LLC 1.23M 股 · $56.46M · Q2 2026
- Vestal Point Capital, LP 935.00K 股 · $43.07M · Q2 2026
- Maverick 资本 925.38K 股 · $42.62M · Q2 2026
- MAVERICK CAPITAL LTD 925.38K 股 · $42.62M · Q2 2026
- Integral Health Asset Management, LLC 900.00K 股 · $41.45M · Q2 2026
- Longaeva Partners L.P. 804.59K 股 · $37.06M · Q2 2026
- Two Seas Capital LP 1.32M 股 · $31.99M · Q3 2026
- First Turn Management, LLC 608.92K 股 · $28.05M · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held QURE?
ORBIMED ADVISORS LLC has disclosed QURE holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in QURE?
As of Q2 2026, ORBIMED ADVISORS LLC holds 1.81M shares of QURE (UNIQURE NV), valued at $83.25M, representing 1.67% of its reported portfolio and ranking #14.
Has ORBIMED ADVISORS LLC been buying or selling QURE?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in QURE. The position peaked in Q2 2026 at 1.81M shares.
Which other funds hold QURE?
Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.